Healthcare
The Pennant Group, Inc.(PNTG)
Live Price
Offline$33.44
-3.30% today
1Y Change
+18.50%
Window
Jun 23, 2025 โ Jun 18, 2026
- Market Cap
- $1.09B
- Revenue Growth
- +36.3%
- EPS Growth
- +19.4%
- Dividend Yield
- 0.0%
Coverage: 249 bars ยท Jun 23, 2025 โ Jun 18, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
The Pennant Group, Inc. (PNTG) is a Healthcare stock with a market cap of $1.09B and listed on NASDAQ. The stock last traded around $33.44 and up 18.5% across the available one-year price window (Jun 23, 2025 โ Jun 18, 2026). Baseline metrics include revenue growth of +36.3%, EPS growth of +19.4%, a dividend yield of 0.0%. What stands out right now is revenue +36.3%, EPS +19.4%, free cash flow -13.2% with operating margin 5.5% and ROIC 4.6%. Valuation already assumes a fairly strong business story at P/E 36.7 and price/sales 1.1. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines PNTG price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Above sector median
+36.3% vs +7.6% peer median
Operating Margin
Below sector median
+5.5% vs +19.4% peer median
P/E
Near sector median
36.7 vs 36.3 peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on May 5, 2026, but the surprise data is still limited.
The operating story is still moving forward
Revenue is running at +36.3% and EPS at +19.4%, with operating margin around 5.5%.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged +4.8% over the next 5 trading days and finished higher after 3 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 May 5, 2026 | โ | +3.4% | +12.6% | -3.5% |
2026 Feb 25, 2026 | +9.7% | -7.9% | +1.4% | -6.0% |
2025 Nov 5, 2025 | +3.5% | -5.6% | +0.3% | +15.0% |
Benchmark Comparison
Normalized Performance vs SPY
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
PNTG
โ
Normalized return
SPY
โ
S&P 500
Excess Return
โ
Relative to SPY
PNTG Max Drawdown
-26.06%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for PNTG and SPY.
Company Overview
The Pennant Group, Inc.
NASDAQ Global Select
The Pennant Group, Inc. provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families. It also provides senior living services, such as residential accommodations, activities, meals, housekeeping, and assistance in the activities of daily living to seniors, who are independent or who require some support. As of December 31, 2021, the company operated 88 home health and hospice agencies, and 54 senior living communities with 4127 Senior Living units in Arizona, California, Colorado, Idaho, Iowa, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. The Pennant Group, Inc. was incorporated in 2019 and is headquartered in Eagle, Idaho.
- Leadership
- Brent J. Guerisoli
- IPO Date
- Oct 1, 2019
- Employees
- 7.0k
- Street Address
- 1675 East Riverside Drive
- Mailing
- Eagle, ID, 83616
- Region
- Eagle, ID, US
- Reporting Currency
- USD
- Investor Line
- 208 506 6100
- Last Updated
- May 3, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- 36.7
- EV/EBITDA
- 25.0
- Price/Sales
- 1.1
- Price/Book
- 3.3
Growth
- Revenue
- +36.3%
- EPS
- +19.4%
- Free Cash Flow
- -13.2%
Profitability
- Gross Margin
- 15.1%
- Operating Margin
- 5.5%
- Net Margin
- 3.1%
- ROE
- 9.3%
- ROIC
- 4.6%
Balance Sheet
- Debt/Equity
- 1.36
- Current Ratio
- 1.14
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.